Recently, specific molecular mutations in the methylation pathway have been identified, including TET2, DNMT3A and IDH/IDH2 [17-19]; however, these methylation machinery genes were detected in only 10-30% of MDS patients [20, 21]. This evidence concerns the gene TET2 and myelodysplastic syndrome.